Genome Technology Program

Developing completely novel approaches and innovations to achieve orders-of-magnitude improvements and refining current technologies to increase efficiency and decrease cost while maintaining or improving data quality.

Overview

The Genome Technology (GTP) program at NHGRI supports research to innovate and develop new methods, technologies and systems that enable rapid, low-cost determination of nucleic acid sequence and genotyping along with epigenetic, functional, and synthetic genomics experiments. The development of completely novel approaches and achieving orders-of-magnitude improvements in genomic technologies are foundational efforts of the program. The refinement of current technologies to increase efficiency and decrease cost while maintaining or improving data quality and the integration of process steps is key to achieving these goals.

The program also supports and coordinates technology transfer from developers to users, and promotes collaborative, multidisciplinary programs that closely integrate research projects in academic and industrial laboratories.

Resources

Genome Technology Development Coordination

The Genome Technology Program supports the Technology Development Coordinating Center (TDCC), which was established to enhance interactions among grantees and accelerate technology innovation. The TDCC facilitates opportunities for grantee collaborations, leads efforts to promote standards in genomic technologies, develops resources to share with the community, and disseminates information about program advances. More information about the coordination efforts and currently funded Genome Technology Program grants can be found on the TDCC website.

You can also learn more about the program and commercialization efforts by viewing our 2023 NHGRI Symposium Poster.

Guidance on GTP Grantee Resource Sharing

To accelerate progress in the field of advanced genomic technology development, grantees will be required to:

Participate actively and openly in at least one grantee meeting per year.
Substantially share information as appropriate; failure to openly share information may be grounds for discontinuation of funding.
Provide access to the technology developed under this grant support and information about that technology.
Develop and implement plan to disseminate any quantity of sequence data if collected under this grant support.

Genome Technology Program Concept Clearances

The following concepts were presented at recent meetings of the National Advisory Council for Human Genome Research and now support active grants within the Genome Technology Program.

NHGRI Technology Development Coordinating Center RFAs - September 18, 2023 Council

Technology Development RFAs – September 16, 2019 Council

Novel Nucleic Acid Sequencing Technology Development – February 12, 2018 Council

Genomic Technology Development – May 18, 2015 Council

Active Funding Opportunities

Advancing Genomic Technology Development for Research and Clinical Application (Notice of Special Interest)

The National Human Genome Research Institute (NHGRI) is issuing this Notice of Special Interest (NOSI) to encourage applications focused on developing novel laboratory-focused tools and technologies that enable new lines of scientific inquiry and clinical applications in human genomics.

R01, R21, R41, R42, R43, R44: NOT-HG-24-036
*First due date is September 5th, 2024; Expiration date is January 10th, 2027*

Inactive Funding Opportunities

NHGRI Technology Development Coordinating Center

U24: RFA-HG-24-013

Advancing Genomic Technology Development for Research and Clinical Application (Notice of Special Interest)

R01, R21, R41, R42, R43, R44: NOT-HG-21-018

Transformative Nucleic Acid Sequencing Technology Innovation and Early Development

Novel Synthetic Nucleic Acid Technology Development

NHGRI Technology Development Coordinating Center

U24: RFA-HG-20-019

Novel Nucleic Acid Sequencing Technology Development

Novel Genomic Technology Development

R01: PAR-18-777
R21: PAR-18-778
R43/R44: PAR-18-779

Technology Development for Single-Molecule Protein Sequencing and Single Cell Proteome Analysis

R01: RFA-HG-21-001
R21: RFA-HG-21-002
R43/R44: PAR-21-247
NOT-HG-23-013: Notice of Early Expiration of RFA-HG-21-001, “Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial Not Allowed)" & RFA-HG-21-002, “Technology Development for Single-Molecule Protein Sequencing (R21 Clinical Trial Not Allowed)"

Advanced Genomic Technology Development Meetings

Each spring the Genome Technology Program holds the Advanced Genomic Technology Development (AGTD) Meeting to provide grantees with a platform to openly discuss key technical and scientific challenges as well as their ongoing work. Linked below are the agendas from past AGTD meetings.

The $1000 Genome Program

NHGRI launched an ambitious program in 2004 to reduce the cost of full mammalian genome sequencing initially by 100-fold and subsequently by an additional 100-fold, aiming ultimately at about $1,000.

Learn more about this groundbreaking program.